Radiotherapy activities and technological equipment in Veneto, Italy: a report from the Rete Radioterapica Veneta
- PMID: 33242206
- DOI: 10.1007/s11547-020-01308-6
Radiotherapy activities and technological equipment in Veneto, Italy: a report from the Rete Radioterapica Veneta
Abstract
Background: Despite the pivotal role of radiotherapy in oncology, the provision of radiation treatments remains inadequate in many areas of the world. The present report is an assessment conducted among Radiation Oncology centers of Veneto region with the aim to collect information concerning radiotherapy assets and technological equipment availability.
Methods: Data concerning Veneto Radiation Oncology departments about radiotherapy activities, number of treatments, techniques used and radiotherapy machines available were collected. The reference time period was 2018. Reimbursement system databases and business intelligence systems were used. Extra-regional attraction and migration were evaluated. When available, data were compared to previous years.
Results: Veneto in 2018 was endowed with 1 megavolt unit for about 153,000 inhabitants. The number of megavolt machines per million inhabitants resulted to be 6.72. In 51% of radiotherapy treatments, intensity-modulated techniques were performed. Six percent of treatments were administered to extra-regional patients.
Conclusion: Radiotherapy assets and equipment in Veneto seem to be appropriate to standard requests in terms of availability and technology.
Keywords: Cancer; Health Economy; Radiotherapy; Resources Management; Technology.
References
-
- I numeri del cancro in Italia 2019 AIOM e AIRTUM 2019. https://www.registri-tumori.it/cms/pubblicazioni/i-numeri-del-cancro-ita...
-
- Registro tumori Veneto. https://www.registrotumoriveneto.it/it/
-
- Delaney G, Jacob S, Featherstone C, Barton M (2005) The role of radiotherapy in cancer treatment. Cancer 104:1129–1137 - DOI
-
- Barton MB, Jacob S, Shafiq J, Wong K, Thompson SR, Hanna TP, Delaney GP (2014) Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol 112:140–144 - DOI
-
- Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, Milosevic M, O’Sullivan B, Rodin DL, Rosenblatt E, Van Dyk J, Yap ML, Zubizarreta E, Gospodarowicz M (2015) Expanding global access to radiotherapy. Lancet Oncol 16:1153–1186 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
